Effect of Liraglutide on Glycaemic Control in Subjects With Type 2 Diabetes.
Effect of Liraglutide on Glycaemic Control in Subjects With Type 2 Diabetes.
This trial is conducted in Europe. The trial is designed to show the effect of treatment with liraglutide or placebo on blood glucose control after 14 weeks in subjects with type 2 diabetes. Liraglutide or placebo is administered by injection once daily in the evening. The trial is a multi-national trial with treatment concealed to participating subjects, investigators and the sponsor. Treatment allocation is random with equal chance of being assigned to each group.
Inclusion Criteria:
Exclusion Criteria:
Århus C, 8000, Denmark